11 - Parenteral Needs Flashcards

1
Q

Why is ENTERAL nutrition preferred > Parenteral Nutrition?

A

Better supports Viscera
Hepatic Protein Synthesis // Regulation of Metabolic Processes

Cost - Effective

Helps maintain:
Functional GUT MUCOSA

EN Administration is MORE CONVIENIENT vs PN

EN is associated with:
LESS severe complications

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Indications for Parenteral Nutrition

A

EN > PN
_*INABILITY* to eat or absorb adequate nutrients via GI tract:_

Massive Small Bowel Resection

Intractable Vomiting / Chronic Malabsorption / Severe Diarrhea

Bowel Rest:
GI Obstruction / Perforated GI tract /
Enterocutaneous Fistula
Pancreatitis

Chemo / Radiation / Eating Disorder

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

TPN vs PPN

Complications:
Needs central line
risk for catheter insertion
higher infxn risk

A

TPN:
Hyperosmolar, Hypertonic Dextrose <35%
AA <10% and FAT
Complete energy & protein Needs = Higher Concentration

Indicated for :
LONG-TERM Supplementation ( >1-2 weeks)

  • *Allows for FLUID RESTRICTION**
  • if necessary*
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

PPN vs TPN

Negatives of PPN:
Needs Peripheral Line
Higher incidense of phlebitis
Frequent IV site changes
less complications with IV insertion vs TPN

A

Limited by Osmolality: < 900 mOsm/L
Max Dextrose = 10% - 12.5%
no FAT –> need to provide
most calories from fat emulsion

Indicated for SHORT duration ( 7-10 days )

Requires LARGE VOLUMES < 3000mL
to meet caloric & protein needs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q
  • *Continuous vs Cyclic**
  • *PN administration**
A

C_ontinuous = Over 24 Hours_:
Constant fluid admin.
Consistant glucose admin w/ those with glucose intolerance
Used in MOST HOSPITILIZED PATIENTS

  • *CYCLIC**
  • MINIMIZES HEPATOTOXICITY*
  • Poor appetite during infusion* / limited IV access
  • *Increase MOBILITY**
  • *HOME BASED CARE**
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Steps for
DESIGNING PN REGIMEN

A
  1. Determine fluid, calorie and protein requirements
  2. Start with 30% of calories from fat unless contraindication
    a. Calculate volume and rate of administration
    b. Calculate fluid left for TPN
  3. Calculate kcal from protein
  4. Calculate grams of glucose based on kcal left
  5. Calculate % dextrose and % protein
  6. Add electrolytes, MVI and trace elements
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Triglyceride Monitoring

A

If fat is infused over 12 hours:
get level 4 hours-post infusion = < 300 mg/dL

If fat is continuous infusion:
goal is <400 mg/dL

Fat should be limited to 5% of total kcal
IF ELEVATED LEVEL

Repeat TG Monitoring WEEKLY

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Electrolytes / BUN / Creatinine

MONITORING

A

ELECTROLYTES AT LEAST DAILY

Generally Daily until Stable –> twice weekly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Electrolyte Adjustments

A

BEFORE making adjustments:
Determine FLUID & Acid-Base STATUS

Requirements are better when:
DOSED PER WEIGHT

Use ABW, unless OBESE
use Adj body weight = IBW +(0.25)(TBW-IBW)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Elevation in LIVER FUNCTION TESTS (LFT)
A Complication of PN

A

Mild Elevation
<3x upper limit of normal
common during first 2-4 weeks of therapy

SEVERE ELEVATION
>5x Upper Limit
REQUIRES MANAGEMENT

Sequence of Elevations:
AST > ALK Phos > Bilirubin

BABIES IS OPPOSITE DIRECTION

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Cause of ELEVATED LFT
&
MANAGEMENT

A

OVERFEEDING = most likely cause
also causes increased Insulin & dextrose -> fat conversion

Management

Reassess Estimated CALORIC NEEDS

AVOID INSULIN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q
  • *Continuous Glucose Infusion**
  • *Management of Liver Complications**
A

Mechanism
Increased INSULIN LEVELS
Enhanced conversion of DEXTROSE –> FAT

Management
CYCLE over 12-16 hours
Monitor fluid & glycemic response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q
  • *Distribution of Macronutrients**
  • *Management of Liver Complications**
A

Mechanism
Increased INSULIN LEVELS
Enhanced conversion of DEXTROSE –> FAT

Management
Provide 70:30 (Dex:Fat)
Adjust Calorie to Nitrogen Ratio to 100:1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Glucose Intolerance
Complication of PN

A

OVERFEEDING is the MOST LIKELY cause
in the non-diabetic patient

Reassess caloric needs & adjust

Addition of insulin should be LAST treatment measure
insulin admin may PROMOTE STEATOSIS in overfed patient

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Refeeding Syndrome

A

Seen in pts with:
Decreased oral intake for extended periods of time
Then as GLUCOSE is initiated –>

causing LOW:
Potassium / Phosphorus / Magnesium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Treatment for Refeeding Syndrome

A
  • *Anticipate Risk:**
  • *1 Major** or 2 Minor risk factors

Check BASELINE ELECTROLYTES: K / P / Mg
BEFORE initiating PN & replace low levels promptly

  • *Initiate PN SLOWLY**
  • *1/2 Glucose Requirements**

Monitor Electrolytes closely
when PN is first initiated –> aggresively replace e- PRN

17
Q

Minor RISK FACTORS
for REFEEDING SYNDROME

Need 2 to say patient is @ HIGH risk

A

BMI < 18.5kg/m2

Uninitentional weight loss > 10%
In previous 3-6 months

Little to no nutrient intake for >5 days

History of:

  • *Alcohol Misuse / Drugs**
  • *Insulin / Chemo / Antacids / Diuretics**
18
Q

MAJOR RISK FACTORS
for REFEEDING SYNDROME

Need 1 to say patient is @ HIGH risk

A

BMI < 16kg/m2

Uninitentional weight loss > 15%
In previous 3-6 months

Little to no nutrient intake for >10 days

  • LOW LEVELS PRIOR to any feeding:*
  • *Potassium / Phosphate / Magnesium**